According to many sufferers, the antibiotic drugs Levaquin, Cipro and Avelox are causing a lot of damage including tendon tears, ruptures and more.
I had the opportunity to interview John Fratti about his experience with Levaquin. As you can see on his youtube video, Fratti has become quite a grassroots activist—passionately voicing his concerns about the possible risks of taking fluoroquinolones, namely Levaquin, Cipro and Avelox (Fratti took Levaquin).
Of course, many lawsuits right now are focusing on Levaquin (distributed by Ortho-McNeil Pharmaceutical) and its association with tendon rupture—not all the effects Fratti talks about here.
However, the antibiotic has come under fire recently for some other adverse effects, including liver damage. The website drugs.com also states that, “in rare cases, Levaquin has caused convulsions and other nervous system disorders… restlessness and tremors to depression and hallucinations… nerve pain, burning or tingling sensations, numbness and/or weakness, or other changes in sense perception.” So maybe Fratti is onto something?
Ok, now we’re getting to some of the harsh realities about the toxic Chinese drywall situation. The AP reported back on June 18th that New Orleans Saints head coach Sean Payton’s home is one of the many affected by defective drywall—and in the meantime, he’s moved out. He’s apparently renting someplace. But see, that takes money, right? And I bet no one’s telling the Payton’s they can just let their mortgage payments (assuming they have them) lapse while they fork over money to rent someplace else. But can the thousands of other homeowners whose lives have been affected by defective Chinese drywall do that? Pretty doubtful.
And Payton clearly understand this: the AP article states Payton “says he feels sorry for residents in Louisiana who have the same problem but can’t afford to make such a move.”
Chances are, given what is now reported on US Consumer Product Safety Commission (CPSC)website regarding the potential health effects of the defective drywall, anyone who has any of these symptoms would most likely want to leave home: Read the rest of this entry »
On July 1, the FDA said it will immediately require boxed warnings about the risk of serious neuropsychiatric symptoms on the packaging of Chantix, a popular smoking cessation drug. The warning is a result of countless reports of behavioral changes, depressed mood, agitation, hostility, and suicidal thoughts and behavior associated with use of the drug.
Chantix is so dangerous that the agency reported 98 suicides and 188 attempted suicides in Chantix users, yet according to Curtis Rosebraugh, MD, director of the agency’s Office of Drug Evaluation II, discontinuation of the medication is not recommended because it has shown to be effective for quitting smoking.
The FDA further recommends, in its infinite wisdom, that “clinicians monitor their patients for neuropsychiatric symptoms after initiating treatment. ” Well, that’s all fine and dandy if you and your doctor have the time, and you have health insurance. But more often than not, people with behavioral changes noted above do not seek medical help, and several people I have spoken with, who have suffered Chantix side effects, can’t afford to see a doctor on a constant basis.
Of course illnesses and deaths caused by smoking has cost a gazillion dollars to the medical system and hey, I’m not condoning smoking but it seems like the FDA needs a lesson in common sense, and reconsider taking Chantix off the market before they have more reported suicides.
First it was the airlines—for which weight discrimination is still a hot topic of debate. But now, it seems American Medical Response (AMR) of Topeka, KS has been given clearance by the Shawnee County Commission to raise its fees for transporting overweight and critical care patients.
According to a June 30th article on ABC affiliate Nebraska.tv, AMR will now be able to increase what it charges for ambulance costs for critical care patients and overweight people from $629 to $1,172. It doesn’t take a math scholar to figure out that it’ll cost you almost double if you tip the scales at over 350 lbs (the threshold weight for the increase). Read the rest of this entry »
The June issue of the American Journal of Roentgenology (as reported by docguide.com) has the results of a new study on MRI health risks–particularly those associated with gadolinium contrast. According to the docguide.com article,
“Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems,…”
That’s a statement that caught my eye given all the prior studies on the risks of gadolinium as an MRI contrast agent and its connection to Nephrogenic Systemic Fibrosis (NSF).
In the study, led by Dr. Mellena D. Bridges, of the Mayo Clinic, Jacksonville, Florida, records of 61 patients who received high-dose IV gadodiamide for catheter angiography or computed tomography (CT) between January 2002 and December 2005 were examined. Read the rest of this entry »